HealthLynked Appoints Jeremy Daniel as New CFO
Portfolio - People | Jan 15, 2025 | EIN
HealthLynked Corp., a healthcare technology solutions provider, has appointed Jeremy Daniel as its new Chief Financial Officer. With over two decades of experience in financial management, strategic planning, and organizational development, Daniel will lead HealthLynked's financial strategy and operations. Daniel's previous role as CFO for Innoveren Scientific demonstrated his capability through successful acquisitions and over $100M raised in funding. HealthLynked CEO, Dr. Michael Dent, expressed confidence in Daniel's ability to enhance the company's financial performance in support of its mission to revolutionize healthcare through technology. Daniel comes equipped with expertise in meeting GAAP and SEC regulations, and holds an MBA and CPA credentials, positioning him for leadership with precision and integrity.
Sectors
- Healthcare Technology
- Biotechnology
- Financial Services
Geography
- United States – HealthLynked Corp. and its new CFO, Jeremy Daniel, are based in the United States, and the company's operations and regulatory obligations are primarily within this country.
Industry
- Healthcare Technology – HealthLynked Corp. is involved in healthcare technology solutions, aiming to connect patients and providers via innovative tech platforms.
- Biotechnology – Jeremy Daniel's previous experience includes working in the biotechnology sector, notably at Innoveren Scientific, which adds relevance to his role in HealthLynked.
- Financial Services – The appointment of a new CFO highlights the importance of financial leadership and strategy within HealthLynked Corp.
Financials
- $100M – Amount raised by Jeremy Daniel through public and private equity markets during his previous role.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| HealthLynked Corp. | Target Company | Company | A healthcare technology company that provides solutions to connect patients and providers. |
| Jeremy Daniel | New Chief Financial Officer | Person | An experienced financial executive, previously CFO at Innoveren Scientific, now joining HealthLynked Corp. |
| Innoveren Scientific | Previous Employer | Company | A publicly traded biotech firm where Jeremy Daniel served as CFO prior to joining HealthLynked. |
| Michael Dent, M.D. | CEO | Person | CEO of HealthLynked Corp. who announced the appointment of Jeremy Daniel as CFO. |